PortfoliosLab logoPortfoliosLab logo

Aspiriant Risk-Managed Equity Allocation Fund (RMEAX) Alternatives

Aspiriant Risk-Managed Equity Allocation Fund (RMEAX) belongs to the Global Equities category. Below you'll find alternative mutual funds from the same category, ranked by key criteria, plus funds that investors commonly compare with RMEAX. Use the tables to find lower-cost options, better risk-adjusted returns, or funds that fit a different role in your portfolio.

Cheapest Alternatives to RMEAX

RMEAX charges 0.28% annually. Among mutual funds in the Global Equities category, these options have the lowest expense ratios among RMEAX alternatives.


Best Risk-Adjusted Alternatives to RMEAX

Among mutual funds in the Global Equities category, these options rank highest on PortfoliosLab's risk-adjusted score, which accounts for volatility, drawdown, and return consistency over a 1-year period.


Top Performing RMEAX Alternatives (YTD)

RMEAX alternatives from the Global Equities category, sorted by year-to-date return.


Lowest Volatility Alternatives to RMEAX

RMEAX alternatives from the Global Equities category, sorted by annualized volatility over the past year.


Lowest Drawdown Alternatives to RMEAX

RMEAX alternatives from the Global Equities category, sorted by maximum drawdown over the past year.


Other Mutual Funds from Aspiriant

Most popular Aspiriant mutual funds on PortfoliosLab, across asset classes.


SymbolNameCategoryRisk / Return RankYTD ReturnInception
Aspiriant Defensive Allocation FundMultistrategy
98
2.53%
Dec 13, 2015RMEAX vs RMDFX

Often Compared With RMEAX

What investors most often compare with RMEAX, based on PortfoliosLab usage data.


Compare RMEAX with Any Fund or Stock

Compare RMEAX with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.